This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cittadini, A. Articles by Saccà, L. Search for Related Content PubMed PubMed Citation Articles by Cittadini, A. Articles by Saccà, L.

Supraphysiological Doses of GH Induce Rapid Changes in Cardiac Morphology and Function

Department of Internal Medicine and Cardiovascular Sciences (A.C., S.L., R.N., S.F., K.C., L.S.), Federico II University, 80131 Naples, Italy; and Department of Medicine (A.B., C.E., T.R., B.-Å.B.), Sahlgrenska University, SE-41345 Gothenberg, Sweden

Address all correspondence and requests for reprints to: Luigi Saccà, M.D., Department of Internal Medicine and Cardiovascular Sciences, Via Sergio Pansini 5, 80131 Naples, Italy. E-mail: . sacca{at}unina.it

Abstract

GH is an agent widely used in sport to improve physical performance and has been proposed as adjunctive therapy in several clinical conditions. However, its short-term effects on the normal human heart are poorly understood.

Sixty young normal volunteers (30 males and 30 females) were enrolled in a multicenter, double-blind, placebo-controlled study. All subjects were randomized to receive GH (0.03 or 0.06 mg/kg·d) or placebo. A complete Doppler-echocardiographic examination was performed at baseline and after 4 wk of treatment.

Low-dose GH did not significantly affect echocardiographic parameters. In contrast, high-dose GH increased left ventricular mass index by 12% (P < 0.05). The type of growth response was concentric, because left ventricular wall thickness but not diameter increased, leading to a 10% increase of relative wall thickness. These structural changes were associated with functional changes, including a significant increase in cardiac index and a decrease in peripheral vascular resistance; diastolic function was not altered. Fractional shortening and systemic blood pressure were unchanged in the two treatment groups.

In conclusion, administration of GH for 4 wk at doses that simulate GH abuse in sport caused a high cardiac output state associated with concentric left ventricular remodeling.

This article has been cited by other articles:

				J. van den Berg, E. M. N. Bannink, P. A. Wielopolski, W. C. J. Hop, L. van Osch-Gevers, P. M. T. Pattynama, S. M. P. F. de Muinck Keizer-Schrama, and W. A. Helbing Cardiac Status after Childhood Growth Hormone Treatment of Turner Syndrome J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2553 - 2558. [Abstract] [Full Text] [PDF]

				H. Liu, D. M. Bravata, I. Olkin, A. Friedlander, V. Liu, B. Roberts, E. Bendavid, O. Saynina, S. R. Salpeter, A. M. Garber, et al. Systematic Review: The Effects of Growth Hormone on Athletic Performance Ann Intern Med, May 20, 2008; 148(10): 747 - 758. [Abstract] [Full Text] [PDF]

				F. Bogazzi, F. Raggi, F. Ultimieri, D. Russo, A. Manariti, A. D'Alessio, P. Viacava, G. Fanelli, M. Gasperi, L. Bartalena, et al. Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH J. Endocrinol., September 1, 2007; 194(3): 521 - 527. [Abstract] [Full Text] [PDF]

				C. A. Bondy, P. L. Van, V. K. Bakalov, and V. B. Ho Growth Hormone Treatment and Aortic Dimensions in Turner Syndrome J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1785 - 1788. [Abstract] [Full Text] [PDF]